Merck researchers pushed for safer, reformulated Vioxx in 2000

NEW YORK (AP) - Merck & Co. researchers privately sought to reformulate Vioxx in 2000 to reduce its cardiovascular side effects, even as the drug maker was publicly playing down a study that highlighted the pain relief medication's potential heart attack risk, an internal company...More